Dr. Joshua M. Shulman, MD, PhD, is a Professor of Neurology, Neuroscience, and Molecular & Human Genetics at Baylor College of Medicine and a leading figure in translational neurogenetics. He serves as the founding Director of the Baylor Center for Alzheimer’s and Neurodegenerative Diseases and the Co-Director of the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital. A board-certified neurologist specializing in memory and movement disorders, Dr. Shulman remains clinically active at facilities such as Baylor St. Luke's Medical Center, where he cares for patients with Alzheimer’s, Parkinson’s, and related neurodegenerative conditions.
Dr. Shulman’s research mission is to bridge the gap between basic genetics and clinical neurology by integrating human genomic analysis with functional investigation in experimental models like Drosophila melanogaster. His laboratory's innovative "bench-to-bedside" approach has revealed key pathways in endolysosomal sorting, RNA metabolism, and synaptic proteostasis, earning him prestigious accolades such as the Burroughs Wellcome Fund Career Award and the American Neurological Association's Derek Denny-Brown Young Neurological Scholar Award. He currently holds the Huffington Foundation Endowed Chair for Parkinson’s Disease Research and the Effie Marie Cain Chair in Alzheimer’s Disease Research.
Dr. Shulman earned his medical degree summa cum laude from Harvard Medical School and a PhD in Genetics from the University of Cambridge. He completed his neurology residency and sub-specialty fellowship training through the Harvard/Partners Program at Brigham & Women’s Hospital and Massachusetts General Hospital before joining the BCM faculty in 2012. Through his leadership at BCM and major consortia like AMP- AD he continues to champion precision medicine strategies to resolve disease heterogeneity and develop personalized treatments for neurodegenerative disorders.
